PD Dr. Jan Dörrie



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia (2019) Harrer DC, Schuler G, Dörrie J, Schaft N Journal article The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy (2019) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1 (2019) Turan A, Grosche L, Krawczyk A, Mühl-Zürbes P, Drassner C, Düthorn A, Kummer M, et al. Journal article The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U Journal article Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race. (2018) Harrer DC, Dörrie J, Schaft N Journal article, Review article BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy (2018) Dörrie J, Babalija L, Hoyer S, Gerer KF, Schuler G, Heinzerling L, Schaft N Journal article Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC (2018) Schierer S, Ostalecki C, Zinser E, Lamprecht R, Plosnita B, Stich L, Dörrie J, et al. Journal article BRAF and MEK inhibitors change human immune cell phenotype and function; possible consequences for combination therapy (2018) Hoyer S, Eberlein V, Babalija L, Gerer K, Walter L, Schuler G, Schaft N, et al. Conference contribution The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Marz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Journal article